logo
Why Surat's gems are losing their shine

Why Surat's gems are losing their shine

India Today15-07-2025
(NOTE: This article was originally published in the India Today issue dated July 21, 2025)Joblessness as an occupational hazard? Yes, and it can be fatal, pretty frequently it seems, for those who work the machines in Surat's diamond industry these days. Last July, Sagar Makwana (21), a polisher, died by suicide after losing his job. Come September, thirtysomething Nikunj Tank went the same way, after a spell of deep depression. He left behind two children and a wife. May this year saw the death of Kapil Nimavat, 45, another jobless diamond worker with two schoolgoing children. The Diamond Workers' Union of Gujarat (DWUG) cites over 100 deaths in the past three years—55 suicides in the past year alone.advertisementHow did we get here? It's a full-blown crisis in the diamond industry. Natural diamond sales saw a severe slump after 2022. Lab Grown Diamonds (LGDs)—70 per cent cheaper—got more popular. Now the global markets are sitting on an unprecedented glut of natural diamonds following a 25-30 per cent wholesale price correction. Over the past three years, manufacturers have had to significantly reduce their output.
In times of such economic distress, the pain primarily flows downward: in this case, the 800,000 diamond artisans of Surat, often migrants from Saurashtra and elsewhere, who form a bulk of the nearly 1.2 million-strong workforce across Gujarat, Rajasthan and Maharashtra. Possibly for the first time in the history of the five-decade-old diamond polishing industry in Surat, 500 workers went on a two-day strike in March, demanding a 30 per cent increase in wages.
In May, the Gujarat government announced an aid package for the industry, the first admission that it is indeed in trouble. The children of certified diamond polishers would get Rs 13,500 school fees, besides power and interest subsidies for small units. But Bhavesh Tank, vice president, DWUG, calls it futile. 'Most companies employ artisans on an informal basis, so proving you are a bona fide employee will be next to impossible,' he says. The fees package practically leaves out younger, unmarried polishers—it assumes they have no dependants. 'Unmarried polishers have younger siblings and old parents as dependants,' says Tank. Their aid coming through depends on proving they have schoolgoing dependant siblings. 'Also, the incentives for small units will not trickle down to the worst-affected artisans as the industry understanding is to reduce the supply of diamonds. They will absorb the government benefits but not increase hours or wages.'As artisans fail to make ends meet, at least a fourth of the trained workforce is believed to have returned to their villages in Saurashtra's Amreli and Bhavnagar districts. Earlier water-starved, the availability of Narmada water has revived farming there. But, says Tank, 'for marginal farmers, agriculture remains risky due to climate threats and volatility in market prices of produce'. What's a side hustle for them? Gig work in diamond polishing. Shashikant Shah, chairman, LGD Council of India, says almost every second village in these districts has a dozen-odd 'ghantis' (diamond polishing wheels). By engaging workers there, 'diamantaires are trying to reduce cost of production while retaining a trained workforce,' he concedes.advertisementWHY SELLERS GO NATURALThough almost every exporter and trader now deals with LGDs, Shah says some admit to it and most don't. Surat itself has 14,000-15,000 LGD machines, according to the LGD Council, followed by 400 in Mumbai, 200 in Jaipur, 25 in Delhi and 200 being planned in Hyderabad. 'With new companies and different brand names, the younger generations educated abroad have taken to LGDs. But the 30-odd big diamantaires have an inventory of natural diamonds worth Rs 200 crore each, so they aggressively defend the traditional system,' he adds. That's led to a paradoxical push: resources have been diverted to marketing natural diamonds over LGDs, a campaign that's yielding some results. In a slack global market, India has risen over China as the second largest destination for the genuine article. But Shah believes the future potential lies with LGD. Survival remains key for all players—whether at the top or the bottom of the pyramid.advertisementSubscribe to India Today Magazine- Ends
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Gujarat remains top exporting state in FY25 with ₹9.83 trn exports: FIEO
Gujarat remains top exporting state in FY25 with ₹9.83 trn exports: FIEO

Business Standard

time4 minutes ago

  • Business Standard

Gujarat remains top exporting state in FY25 with ₹9.83 trn exports: FIEO

Gujarat retained its position as India's top exporting state in 2024-25, with outbound shipments worth Rs 9.83 lakh crore, accounting for 26.6 per cent of the country's total exports, FIEO said on Tuesday. It said despite a marginal dip from the previous year, Gujarat's exports remained significantly ahead of all other states, nearly Rs 4.3 lakh crore more than Maharashtra (Rs 5,57,271 crore), the second-ranked state. Maharashtra is followed by Tamil Nadu, Karnataka, Uttar Pradesh, Andhra Pradesh and Telangana, according to the analysis of the Federation of Indian Export Organisations (FIEO). "In 2024-25, Gujarat reaffirmed its leadership as India's top exporting state, accounting for Rs 9.83 lakh crore, which is 26.6 per cent of the country's total exports," it said. It added that Gujarat's export dominance continues to be driven by a few high-performing districts, with Jamnagar maintaining a commanding lead at Rs 3.63 lakh crore, largely owing to its petroleum and refinery exports. Jamnagar contributes over one-third of the state's total. The top five export commodities from the state are Petroleum Products, Gems and Jewellery, Organic Chemicals, Pharmaceuticals, and Engineering Goods (Machinery). In 2024-25, Uttar Pradesh contributes Rs 1.86 lakh crore to India's total exports of Rs 37.02 lakh crore. This accounts for 5 per cent of the country's total exports, positioning Uttar Pradesh as an important player in India's export landscape. "Uttar Pradesh has demonstrated a commendable diversification in its export markets, reaching both traditional and emerging economies across continents," it said, adding that the US continues to be the top export destination of the state.

Eris Lifesciences to tap Rs 5,000-cr insulin and semaglutide market in FY26
Eris Lifesciences to tap Rs 5,000-cr insulin and semaglutide market in FY26

Business Standard

time4 minutes ago

  • Business Standard

Eris Lifesciences to tap Rs 5,000-cr insulin and semaglutide market in FY26

Ahmedabad-based Eris Lifesciences is looking to tap opportunities in the nearly Rs 5,000-crore Indian insulin market after Danish drugmaker Novo Nordisk announced the withdrawal of its insulin products from the market in April this year. 'We expect that Novo's cartridge inventory in the market will run out by October 2025. So this market opportunity is something that one can start monetising from the November–December time frame,' the company's executive director and chief executive officer (CEO), Krishnakumar Vaidyanathan, told Business Standard. He added that the timing fits Eris' plans, as the cartridge filling capability of its Bhopal unit will start becoming operational from January. Vial manufacturing has already been commissioned at the unit, with the company creating a strategic stock of insulins. This comes at a time when Eris is already the largest domestic player in insulins. The company had acquired the India formulations business of Biocon Biologics last year — including established insulin brands Basalog and Insugen. 'Before the Biocon deal, we had a couple of homegrown insulin brands in the market, which did a combined Rs 60 crore in revenue last year. Basalog and Insugen had combined revenues of Rs 200 crore at the time of acquisition,' he said. He added that, with this, the company's insulin franchise has become significantly larger, with a 10 per cent market share. Eris is also among the prominent drugmakers looking to roll out generic versions of the blockbuster molecule semaglutide once its patent expires around March next year. Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist used as an active pharmaceutical ingredient in medications for obesity management and Type-II diabetes. According to Eris' investor presentation for the June quarter of 2025–26 (Q1FY26), the company is on track to be among the first launches in India in March 2026. The company has initiated validation of synthetic semaglutide cartridges at its European Union (EU)-approved AMD injectables site. 'We are also planning the validation of the recombinant semaglutide in our Bhopal plant later this year,' he added. As far as the go-to-market strategy is concerned, the company said it is already in a strong position because of its dominant presence in insulins and prior presence in the GLP market with the launch of liraglutide in September last year. For Q1FY26, Eris Lifesciences recorded a 40 per cent year-on-year (Y-o-Y) rise in consolidated profit after tax (PAT) to Rs 125 crore. Revenue rose to Rs 773 crore during the June quarter against Rs 720 crore in the year-ago period.

Britannia Q1 profit dips 0.8% YoY; revenue up 8.8%, misses estimates
Britannia Q1 profit dips 0.8% YoY; revenue up 8.8%, misses estimates

Economic Times

time4 minutes ago

  • Economic Times

Britannia Q1 profit dips 0.8% YoY; revenue up 8.8%, misses estimates

Biscuit major Britannia Industries Ltd reported a marginal 0.8% year-on-year (yoy) drop in standalone net profit at Rs 498.27 crore for the first quarter ending June 30th, while standalone revenue from operations grew 8.8% YoY at Rs 4,452.74 crore. The performance during the quarter missed street estimates. ADVERTISEMENT The company did not attribute any reason behind the fall in profit. Britannia's managing director Varun Berry said in the earnings release that there was a marginal uptick in consumption across both urban and rural markets in the quarter under review, underpinned by moderating inflation which helped (near) double-digit growth after the last few periods. Berry said as the year progresses, the company's focus will remain on sustaining a healthy growth trajectory while protecting margins amidst a heightened competitive landscape across product categories. "We aim to further reinforce our market leadership through continued investments in brand building and innovations," he said. Britannia's consolidated revenue from operations for the quarter went up by 8.8% yoy at Rs 4,622.22 crore while net profit grew by 3% yoy at Rs 520.13 crore. Consolidated sales for the quarter grew 9.8% at Rs 4,535 said the company had a robust double-digit growth across our focus markets and in adjacent bakery categories such as rusk, wafers and croissant. He said the company's performance during the quarter underscores the effectiveness of its focused execution strategy -- maximizing value from existing outlets, more agile servicing to key stores, and driving operational efficiencies across distribution networks. ADVERTISEMENT On Tuesday, Britannia's shares closed 2.66% down on the BSE at Rs 5,631.35 a piece. The results were declared after market hours. The company in a stock market notice said the board of directors authorized chairman Nusli N. Wadia to sign the results which were submitted to the stock exchanges. (You can now subscribe to our ETMarkets WhatsApp channel)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store